IRIS
MARTINELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 436
EU - Europa 239
AS - Asia 128
OC - Oceania 2
AF - Africa 1
Totale 806
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 433
IE - Irlanda 169
CN - Cina 92
FI - Finlandia 26
SG - Singapore 20
IT - Italia 18
DE - Germania 15
TR - Turchia 4
IN - India 3
JP - Giappone 3
AT - Austria 2
AU - Australia 2
BE - Belgio 2
GB - Regno Unito 2
IL - Israele 2
MX - Messico 2
UA - Ucraina 2
CA - Canada 1
CZ - Repubblica Ceca 1
GR - Grecia 1
KG - Kirghizistan 1
NL - Olanda 1
TH - Thailandia 1
TM - Turkmenistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 806
Salva come PNG Salva come JPEG
Città #
Dublin 169
Chandler 128
Boardman 36
Ashburn 33
Helsinki 26
Lawrence 21
Princeton 21
Medford 20
Nanjing 20
New York 19
Shanghai 18
Shenyang 10
Singapore 10
Beijing 9
Nanchang 9
Wilmington 9
Los Angeles 8
Changsha 6
Cagliari 4
Chicago 4
Hebei 4
Istanbul 4
Norwalk 4
Pavia 4
Jiaxing 3
Redwood City 3
Seattle 3
Tianjin 3
Tokyo 3
Washington 3
Woodbridge 3
Anzio 2
Brisbane 2
Brussels 2
Fairfield 2
Guangzhou 2
Hangzhou 2
Jacksonville 2
Puebla City 2
Verona 2
Amsterdam 1
Ann Arbor 1
Ashgabat 1
Athens 1
Atlanta 1
Bangkok 1
Bhubaneswar 1
Bishkek 1
Brescia 1
Brno 1
Centurion 1
Como 1
Dallas 1
Germantown 1
Haifa 1
Houston 1
Kurnool 1
London 1
Munich 1
Portland 1
Pune 1
Rome 1
Santa Clara 1
Shenzhen 1
South Shields 1
Taizhou 1
Tel Aviv 1
Toronto 1
Vienna 1
Totale 664
Salva come PNG Salva come JPEG
Nome #
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 55
Frontal and cerebellar atrophy supports FTSD-ALS clinical continuum 48
A machine learning approach for the differential diagnosis of Alzheimer and vascular dementia fed by MRI selected features. 45
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 45
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm 43
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: Additional findings from the randomized, sham-controlled, double-blind PRESTO trial 11 Medical and Health Sciences 1103 Clinical Sciences 42
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 41
Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial 39
Functional and structural MRI signature of the induced migraine attack 38
Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study 38
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults 37
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 37
Peripheral vagal nerve stimulation modulates the nociceptive withdrawal reflex in healthy subjects: A randomized, cross-over, sham-controlled study 36
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study 34
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults 33
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 32
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 32
Migraine neuroscience: from experimental models to target therapy 30
Chronic migraine and Botulinum Toxin Type A: Where do paths cross? 27
Lasmiditan: an additional therapeutic option for the acute treatment of migraine 26
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 24
Thalamocortical connectivity in experimentally-induced migraine attacks: A pilot study 23
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine 21
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 7
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 3
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 3
Totale 839
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 1 0 6 4
2020/202129 2 0 0 3 1 11 1 8 2 1 0 0
2021/202271 0 1 1 0 0 0 0 10 3 0 9 47
2022/2023375 36 36 1 32 28 28 1 14 180 6 11 2
2023/2024199 34 20 8 17 19 38 4 20 4 10 6 19
2024/202578 22 33 21 2 0 0 0 0 0 0 0 0
Totale 839